Literature DB >> 11796228

Regulation of gene expression by the proto-oncogene BCL-6.

Alexander L Dent1, Farha H Vasanwala, Lisa M Toney.   

Abstract

The proto-oncogene BCL-6 encodes a transcriptional repressor protein that is expressed at high levels in germinal center B cells and lymphomas with a germinal center B cell phenotype. The BCL-6 gene is a frequent target of chromosomal translocations, micro-deletions, and point mutations in non-Hodgkin's lymphoma. Studies of BCL-6-deficient mice have revealed that BCL-6 is critical for normal lymphocyte differentiation and also that BCL-6 is a negative regulator of inflammation. Recent studies have shed light on how BCL-6 controls these processes by showing that BCL-6 regulates a broad spectrum of target genes. BCL-6 represses transcription of genes involved in lymphocyte activation, differentiation, proliferation, and migration. Although much progress has been made in understanding gene regulation by BCL-6, many important questions are unresolved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796228     DOI: 10.1016/s1040-8428(01)00164-0

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  34 in total

1.  C5a-induced gene expression in human umbilical vein endothelial cells.

Authors:  Eric A Albrecht; Arul M Chinnaiyan; Sooryanarayana Varambally; Chandan Kumar-Sinha; Terrence R Barrette; J Vidya Sarma; Peter A Ward
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

Review 2.  Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6.

Authors:  Saritha Kusam; Alexander Dent
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.

Authors:  Srividya Swaminathan; Cihangir Duy; Markus Müschen
Journal:  Trends Immunol       Date:  2013-12-10       Impact factor: 16.687

4.  The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.

Authors:  Beverly W Baron; Rebecca M Baron; Joseph M Baron
Journal:  Biochim Biophys Acta       Date:  2014-12-31

5.  Bcl6 gene-silencing facilitates PMA-induced megakaryocyte differentiation in K562 cells.

Authors:  Sedigheh Eskandari; Razieh Yazdanparast
Journal:  J Cell Commun Signal       Date:  2017-06-06       Impact factor: 5.782

6.  Point mutation of 5' noncoding region of BCL-6 gene in primary gastric lymphomas.

Authors:  Da-Liu Min; Xiao-Yan Zhou; Wen-Tao Yang; Hong-Fen Lu; Tai-Ming Zhang; Ai-Hua Zhen; Pei-Zheng Cao; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

7.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

8.  B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells.

Authors:  Cornelia Muschol-Steinmetz; Britta Jasmer; Nina-Naomi Kreis; Kerstin Steinhäuser; Andreas Ritter; Udo Rolle; Juping Yuan; Frank Louwen
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

9.  Rac1 signaling modulates BCL-6-mediated repression of gene transcription.

Authors:  Patrícia Barros; Peter Jordan; Paulo Matos
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

10.  Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.

Authors:  Lucas Ravaux; Chantal Denoyelle; Claire Monne; Isabelle Limon; Michel Raymondjean; Khadija El Hadri
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.